IGIM
BIO icon

I.G. Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

I.G. Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,535
Closed -$363K – 896
2016
Q2 		$363K Buy
2,535
+217
+9% +$31K ﹤0.01% 789
2016
Q1 		$317K Buy
2,318
+521
+29% +$68.4K ﹤0.01% 802
2015
Q4 		$249K Buy
1,797
+405
+29% +$56.1K ﹤0.01% 816
2015
Q3 		$187K Buy
+1,392
New +$200K ﹤0.01% 815

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

I.G. Investment Management's BIO Position: Q3 2016 in Review

I.G. Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2016, closing a stake of 2,535 shares — an estimated $363K sold.

I.G. Investment Management first reported a position in BIO in Q3 2015 and held it in 4 quarters. The position peaked at $363K in Q2 2016. 241 funds tracked by Wall St. Rank hold BIO as of Q3 2016.

  • I.G. Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2016 after selling out during the quarter.
  • I.G. Investment Management sold 2,535 Bio-Rad Laboratories Class A shares in Q3 2016, an estimated $363K.
  • I.G. Investment Management first reported a position in Bio-Rad Laboratories Class A in Q3 2015 and held it in 4 quarters.
  • I.G. Investment Management's Bio-Rad Laboratories Class A position peaked at $363K in Q2 2016.
  • 241 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2016.

Based on I.G. Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.